Innospec Inc forecasts earnings growth for the September 2026 quarter, releasing results November 3. Analysts expect 13.4% year-over-year EPS growth, though a Hold rating indicates uncertainty on beat
Innospec Inc., a specialty chemicals company, presents an overview of its stock price, financial performance, and analyst ratings. The report details key statistics and operational segments to provide
Innospec faces expected year-over-year earnings declines despite rising revenue, with negative sentiment suggesting an earnings miss following its removal from Russell indices. Management aims to addr
Innospec Inc (IOSP) ranks 12th out of 65 in the Chemicals industry with a risk score of 8.57, exhibiting lower market volatility with a beta value of 0.90.
Innospec Inc. was removed from several Russell growth and small-cap indices, potentially impacting its passive demand and risk profile. Despite this, the company's core specialty chemicals business an
Analysts project Innospec Inc.'s stock trajectory through 2027, outlining price targets, market cap, and earnings estimates based on current financial performance.
Innospec Inc holds a valuation score of 7.44, ranking 52nd among 68 chemicals companies, with a P/E ratio of 17.93 while other key ratios remain undisclosed.
Innospec Inc. raised dividends and authorized share repurchases despite weaker Q1 earnings, signaling confidence amid margin pressures in its chemicals business. Investors are assessing how these capi
ChemBrief